|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C12Q 1/6883 | (2013.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Patento numeris | 3719139 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20156494.5 |
| Europos patento paraiškos padavimo data | 2009-10-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-10-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-11-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 106491 P | 2008-10-17 | US |
| (72) |
HARLEY, Calvin B. , US
ELIAS, Laurence , US
SMITH, Jennifer , US
RATAIN, Mark J. , US
BENEDETTI, Fabio , US
|
| (73) |
Geron Corporation ,
919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404,
US
|
| (54) | METHOD FOR IDENTIFICATION OF SENSITIVITY OF A PATIENT TO TELOMERASE INHIBITION THERAPY |
| METHOD FOR IDENTIFICATION OF SENSITIVITY OF A PATIENT TO TELOMERASE INHIBITION THERAPY |